Document Detail

Indications for Cardiac Pacemaker Implantation in Myotonic Dystrophy.
MedLine Citation:
PMID:  11104407     Owner:  NLM     Status:  Publisher    
OBJECTIVES: To determine risk factors for cardiac complications in patients with myotonic dystrophy, and to determine whether permanent cardiac pacemakers may be beneficial in the treatment of myotonic dystrophy heart disease. BACKGROUND: Myotonic dystrophy affects the cardiac conduction system. Cardiac pacemakers are easily implanted and can be life-saving in patients with severe or complete heart block. METHODS: A total of 94 patients with myotonic dystrophy were examined; 46 were followed for a mean of 6.4 (+/- 3.5 SD) years to determine predictors of the end point events of sudden death, Stokes-Adams attacks, or onset of atrial fibrillation. The end points were chosen to determine when cardiac pacemakers should be implanted (Fig. 1). RESULTS: Four out of 5 patients (and all 4 patients >60 years of age) with PR intervals longer than 275 msec had sudden death (n=1), Stokes-Adams attacks (n=1), or onset of atrial fibrillation (n=2). Conversely, only 1 of 89 patients with a PR interval shorter than 275 msec had end point events; 1 patient, aged 63 years, developed left bundle branch block and palpitations accompanied by dyspnea, which responded to a pacemaker. CONCLUSIONS: We recommend that patients with myotonic dystrophy and any indication or a family history of myotonic heart disease have at least a yearly electrocardiogram, particularly if they have a prolonged baseline or progressively increasing PR interval, or symptoms suggestive of heart block.
Hawley; Colleran; Fletcher; Verdino; Kokkinos; Pinnow
Related Documents :
12208227 - Treatment of superior vena cava obstruction secondary to pacemaker wires with balloon v...
25448027 - An approach to rule-out an acute cardiovascular event or death in emergency department ...
3409317 - The paceport catheter: a new pacemaker system introduced through a swan-ganz catheter.
6887977 - Reentrant tachycardia associated with atrial synchronous pacing. report of a case with ...
21410727 - Atrial flutter a manifestation of cardiac tamponade.
7645527 - From antianginal drugs to myocardial cytoprotective agents.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  1999-Sep-7
Journal Detail:
Title:  MedGenMed : Medscape general medicine     Volume:  -     ISSN:  1531-0132     ISO Abbreviation:  MedGenMed     Publication Date:  1999 Sep 
Date Detail:
Created Date:  2000-12-04     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100894134     Medline TA:  MedGenMed     Country:  -    
Other Details:
Languages:  ENG     Pagination:  E5     Citation Subset:  -    
Georgetown University Medical School.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  How Fast Can the Racial Gap in Life Expectancy Between Whites and Blacks Be Eliminated?
Next Document:  Delay in Treatment of Pulmonary Tuberculosis: An Analysis of Symptom Duration Among Ethiopian Patien...